Wenrui Liu Selected Research

human TXNIP protein

3/2009	Thioredoxin binding protein-2/thioredoxin-interacting protein is a critical regulator of insulin secretion and peroxisome proliferator-activated receptor function.
1/2006	Impaired fatty acid utilization in thioredoxin binding protein-2 (TBP-2)-deficient mice: a unique animal model of Reye syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wenrui Liu Research Topics

Disease

3	Fibrosis (Cirrhosis) 01/2022 - 01/2020
3	Wounds and Injuries (Trauma) 01/2021 - 12/2010
2	Hypoxia (Hypoxemia) 12/2022 - 03/2018
2	Inflammation (Inflammations) 04/2016 - 02/2006
2	Hypoglycemia (Reactive Hypoglycemia) 12/2010 - 03/2009
1	Myocardial Infarction 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Nephrolithiasis 01/2021
1	COVID-19 06/2020
1	Peritoneal Fibrosis 01/2020
1	Hypertrophy 01/2020
1	Tuberous Sclerosis (Bourneville's Disease) 01/2020
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2020
1	Neoplasms (Cancer) 04/2016
1	Adenocarcinoma of Lung 04/2016
1	Lung Neoplasms (Lung Cancer) 04/2016
1	Airway Remodeling 08/2015
1	Vascular Remodeling 08/2015
1	Respiratory Hypersensitivity 08/2015
1	Hyperinsulinism (Hyperinsulinemia) 12/2010
1	Endotoxemia 12/2010
1	Hypertriglyceridemia 03/2009
1	Hypersensitivity (Allergy) 05/2008
1	Hemorrhage 01/2006
1	Reye Syndrome (Reye's Syndrome) 01/2006
1	Gastritis 09/2005
1	Myocarditis (Carditis) 09/2004
1	Heart Diseases (Heart Disease) 09/2004

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 12/2022 - 03/2009
3	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 12/2010
3	tributyl phosphate (TBP)IBA 03/2009 - 01/2006
3	ThioredoxinsIBA 03/2009 - 09/2004
2	NLR ProteinsIBA 01/2022 - 04/2016
2	InflammasomesIBA 01/2022 - 04/2016
2	OxalatesIBA 01/2021 - 01/2018
2	Fatty Acids (Saturated Fatty Acids)IBA 12/2010 - 01/2006
2	human TXNIP proteinIBA 03/2009 - 01/2006
1	Cadherins (E-Cadherin)IBA 12/2022
1	VimentinIBA 12/2022
1	XAV939IBA 12/2022
1	CateninsIBA 12/2022
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2022
1	Hematoxylin (Haematoxylon)IBA 01/2022
1	Therapeutic UsesIBA 01/2022
1	Calcium OxalateIBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	GlycosyltransferasesIBA 01/2021
1	Angiotensin IIIBA 01/2020
1	Cyclin-Dependent Kinase Inhibitor p27IBA 01/2020
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2020
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2020
1	HydrogenIBA 01/2020
1	Long Noncoding RNAIBA 01/2020
1	Tripartite Motif ProteinsIBA 01/2020
1	Dialysis SolutionsIBA 01/2020
1	trans-sodium crocetinate (crocetin)IBA 01/2020
1	Competitive Endogenous RNAIBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	BerberineIBA 03/2018
1	p38 Mitogen-Activated Protein KinasesIBA 01/2018
1	LuteolinIBA 01/2018
1	GenisteinIBA 01/2018
1	ApigeninIBA 01/2018
1	NucleotidesIBA 04/2016
1	N- (1- methylethyl)- 1,1,2- trimethylpropylamineIBA 08/2015
1	KATP ChannelsIBA 08/2015
1	CytokinesIBA 12/2010
1	GlycogenIBA 12/2010
1	Insulin (Novolin)FDA Link 12/2010
1	LipidsIBA 12/2010
1	LipopolysaccharidesIBA 12/2010
1	Nonesterified Fatty Acids (NEFA)IBA 12/2010
1	EndotoxinsIBA 12/2010
1	CholesterolIBA 12/2010
1	Triglycerides (Triacylglycerol)IBA 12/2010
1	OvalbuminIBA 05/2008
1	Immunoglobulin E (IgE)IBA 02/2006
1	ChemokinesIBA 09/2004
1	Myosins (Myosin)IBA 09/2004
1	Cardiac MyosinsIBA 09/2004

Therapy/Procedure

2	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2022 - 06/2020
1	Traditional Medicine (Folk Remedies) 01/2021
1	Peritoneal Dialysis 01/2020
1	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2020
1	Intraperitoneal Injections 01/2020